Topic: Value chains

A plant can be wild, cultivated, or both. Those are different responsibilities. Wild plants need a reason not to harvest them. Cultivated plants need proof that the seed or cutting is the species it claims to be.

Healthcare, if it comes later, depends on that identity. This essay does not name a disease or a product that “works”.

Three different plants

• A wild plant. The first question is conservation, not a buyer.
• A cultivated plant. The first question is whether the planting material is the species it claims to be.
• A traded material with only a common name. The first question is identity.

Manufacturers ask for ingredients, markers, and a steady supply. A public answer can say what must be documented. It cannot, on this page, name a marker and call it proof of a health effect.

Phytopharmaceutical and extract work belongs in a feasibility review with sources attached, not in a slogan.

What a buyer can be told here

An extract is not “the plant” unless the plant was identified and the process is documented. A public page can list the documents a later dossier needs. It cannot name a chemical marker and call that proof of a health effect.

Trade in herbal materials is large and uneven. Quality failures are usually failures of identity, substitution, or records.

Regulation is set by the authorities, not by this website. Readers can start from the Ministry of AYUSH, the National Medicinal Plants Board, and the National Biodiversity Authority. A link is not a partnership.

Where to check the rules

Start with the Ministry of AYUSH, the National Medicinal Plants Board, and the National Biodiversity Authority. Those links are on the references page. They are not a statement that Dr Chandan represents those institutions.